SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-062212
Filing Date
2019-11-12
Accepted
2019-11-12 09:24:25
Documents
6
Period of Report
2019-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22537_18k.htm 8-K 34817
2 EX-10.1 a19-22537_1ex10d1.htm EX-10.1 402095
3 EX-10.2 a19-22537_1ex10d2.htm EX-10.2 219053
4 EX-99.1 a19-22537_1ex99d1.htm EX-99.1 12395
5 GRAPHIC g225371mmi001.jpg GRAPHIC 4115
6 GRAPHIC g225371mmi002.jpg GRAPHIC 1995
  Complete submission text file 0001104659-19-062212.txt   678296
Mailing Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173
Business Address 340 MADISON AVENUE 19TH FLOOR NEW YORK NY 10173 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 191206584
SIC: 2834 Pharmaceutical Preparations